Walleye Capital
INSM icon

Walleye Capital’s Insmed INSM Stock Holding History

Walleye Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Sell
1,384
-70,435
-98% -$8.53M ﹤0.01% 3684
2026
Q1 		$11.7M Buy
71,819
+55,999
+354% +$8.61M 0.05% 342
2025
Q4 		$2.75M Buy
15,820
+8,890
+128% +$1.62M 0.01% 1600
2025
Q3 		$998K Sell
6,930
-81,476
-92% -$9.98M ﹤0.01% 2099
2025
Q2 		$8.9M Buy
88,406
+53,928
+156% +$4.12M 0.03% 564
2025
Q1 		$2.63M Buy
+34,478
New +$2.64M 0.01% 1230
2024
Q4 		– Sell
-63,477
Closed -$4.57M – 5171
2024
Q3 		$4.63M Buy
63,477
+17,550
+38% +$1.3M 0.01% 1235
2024
Q2 		$3.08M Sell
45,927
-145,215
-76% -$5.63M 0.01% 1702
2024
Q1 		$5.19M Buy
191,142
+72,731
+61% +$2.04M 0.01% 1264
2023
Q4 		$3.67M Buy
118,411
+46,341
+64% +$1.2M 0.01% 1313
2023
Q3 		$1.82M Buy
+72,070
New +$1.65M ﹤0.01% 1808
2023
Q2 		– Sell
-66,440
Closed -$1.13M – 4569
2023
Q1 		$1.13M Buy
+66,440
New +$1.29M 0.02% 1075
2022
Q4 		– Sell
-186,462
Closed -$4.02M – 3393
2022
Q3 		$4.02M Buy
186,462
+62,177
+50% +$1.49M 0.08% 278
2022
Q2 		$2.45M Buy
124,285
+17,323
+16% +$363K 0.07% 306
2022
Q1 		$2.51M Buy
106,962
+57,325
+115% +$1.33M 0.07% 304
2021
Q4 		$1.35M Buy
+49,637
New +$1.42M 0.04% 443

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Walleye Capital's INSM Position: Q2 2026 in Review

Walleye Capital reduced its Insmed (INSM) stake by 98% in Q2 2026, selling an estimated $8.53M and leaving 1,384 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #3684.

Walleye Capital first reported a position in INSM in Q4 2021 and has held it in 16 quarters since. The position peaked at $11.7M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Walleye Capital held 1,384 shares of Insmed worth $148K as of Q2 2026.
  • Walleye Capital sold 70,435 Insmed shares in Q2 2026, an estimated $8.53M.
  • Insmed made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3684 holding.
  • Walleye Capital first reported a position in Insmed in Q4 2021 and has held it in 16 quarters since.
  • Walleye Capital's Insmed position peaked at $11.7M in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.